Type of Cancer
Leukemia
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.